Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapseAnna Sureda, E. Condé, María‐Jesús Vidal et al.|Annals of Oncology|2005Cited by 220
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 studyJuan José Lahuerta, M.V. Mateos, Joaquín Martínez‐López et al.|Haematologica|2010Cited by 113
Autologous stem cell transplantation for primary refractory Hodgkin’s disease: results and clinical variables affecting outcomeM. Constans, E. Condé, Anna Sureda et al.|Annals of Oncology|2003Cited by 46